Ginger Gregory - 08 Feb 2023 Form 4 Insider Report for BIOGEN INC. (BIIB)

Reporting relationship
EVP, Human Resources
Issuer ticker
BIIB
Reported as of
08 Feb 2023
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
10 Feb 2023, 17:45:36 UTC
Prior SEC filing
27 Jan 2023
Next SEC filing
14 Feb 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Wendell Taylor, attorney in fact for Ginger Gregory

Key filing fact

Ginger Gregory filed Form 4 for BIOGEN INC. (BIIB) on 10 Feb 2023.

Key facts

  • This page summarizes Ginger Gregory's Form 4 filing for BIOGEN INC. (BIIB).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 10 Feb 2023, 17:45.

Change

  • Previous filing in this sequence was filed on 27 Jan 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BIIB holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
10,163
Date
08 Feb 2023
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BIIB transaction Derivative

Restricted Stock Unit

Award

Transaction value
$0
Shares
+4,905
Change %
Price
$0.000000
Shares after
4,905
Date
08 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,905
Exercise price
$0.000000
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/08/2023.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .